TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15879427

Group type: EXPERIMENTAL
Intervention: CXCR3 activation by airway smooth muscle cultures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CXCL10 expression in asthmatic airway smooth muscle
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunohistology and enzyme-linked immunosorbent assay
Number of subjects: 0
Study: 12794265

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LJP 394
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-CD40L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monoclonal anti-IL-10
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blocking peptides (LJP394)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IVIg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stem-cell restoration
Number of subjects: 0
Study: 10584878

Group type: EXPERIMENTAL
Intervention: Detection of circulating tumour cells using MACS and FISH
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Detection of chromosomal aberrations in circulating tumour cells
Number of subjects: 48
Study: 8981894

Group type: EXPERIMENTAL
Intervention: Transverse osteotomy with 0.062 Kirschner wire and tension band fixation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chevron osteotomy with 6.5‐mm cancellous lag screw and tension band fixation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Oblique intraarticular osteotomy with 3.5‐mm cortical lag screw and tension band fixation
Number of subjects: 36

Group type: COMPARATOR
Intervention: All techniques (Transverse, Chevron, Oblique)
Number of subjects: 36
Study: 1464208

Group type: EXPERIMENTAL
Intervention: 5 mg hyoscine-N-butylbromide
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 10 mg hyoscine-N-butylbromide
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 20 mg hyoscine-N-butylbromide
Number of subjects: 120
Study: 6322992

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 31551219

Group type: EXPERIMENTAL
Intervention: Oxycodone (O) alone postoperatively
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with oxycodone (DO) postoperatively
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (D) alone postoperatively
Number of subjects: 90
Study: 29378622

Group type: EXPERIMENTAL
Intervention: Mobile text messaging and community-based mentor mothers (cMMs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community-based mentor mothers (cMMs) only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mobile text messaging only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing standard of care
Number of subjects: 0
Study: 27585725

Group type: EXPERIMENTAL
Intervention: Positive suggestions (verbal before and audiotaped during surgery)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no positive suggestions)
Number of subjects: 95
Study: 24835382

Group type: EXPERIMENTAL
Intervention: Face-to-face structured conversation about end-of-life care options with family members.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Social contact via telephone (comparison group).
Number of subjects: 0
Study: 23168756

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 145

Group type: COMPARATOR
Intervention: Atosiban
Number of subjects: 145
Study: 20205269

Group type: EXPERIMENTAL
Intervention: Optimal weighted combination of pseudo-likelihood estimators
Number of subjects: 0

Group type: COMPARATOR
Intervention: Independence working assumption pseudo-likelihood
Number of subjects: 0

Group type: COMPARATOR
Intervention: Protective estimator pseudo-likelihood
Number of subjects: 0
Study: 18609291

Group type: EXPERIMENTAL
Intervention: Hydration scheme of 290 ml of water/m2
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hydration scheme of 580 ml of water/m2
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Continuous urinary drainage by catheter
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Phase 2 (24 hours after Phase 1)
Number of subjects: 45
Study: 16082646

Group type: EXPERIMENTAL
Intervention: Tramadol/acetaminophen
Number of subjects: 313

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study: 11858378

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (administered to 7 patients for 4 months)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (administered to 5 patients for 4 months)
Number of subjects: 12
Study: 10360847

Group type: COMPARATOR
Intervention: Control Group (CG) - additional 20 mg oral morphine (10 mg at 12-h intervals)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dipyrone Group (DG) - 500 mg oral dipyrone at 6-h intervals
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nitroglycerin Group (NG) - 5 mg nitroglycerin patch daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ketamine Group (KG) - 0.5 mg/kg oral ketamine at 12-h intervals
Number of subjects: 60
Study: 7949225

Group type: EXPERIMENTAL
Intervention: Diabetic patients with neurological disorders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diabetic patients without neuropathy
Number of subjects: 0
Study: 3345072

Group type: EXPERIMENTAL
Intervention: Amphetamine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31935605

Group type: EXPERIMENTAL
Intervention: Bactiguard ETT
Number of subjects: 90

Group type: COMPARATOR
Intervention: Taperguard ETT
Number of subjects: 90
Study: 29568106

Group type: EXPERIMENTAL
Intervention: Children of university-educated mothers
Number of subjects: 12385

Group type: EXPERIMENTAL
Intervention: Children of university-educated mothers at age 7
Number of subjects: 12385

Group type: EXPERIMENTAL
Intervention: Children of university-educated mothers after controlling for parental BMI
Number of subjects: 12385
Study: 28454528

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol (FP/SAL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP)
Number of subjects: 0
Study: 25058803

Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 59
Study: 22753629

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 17668144

Group type: COMPARATOR
Intervention: TVT-O procedure
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Monarc procedure
Number of subjects: 120
Study: 15715551

Group type: EXPERIMENTAL
Intervention: CeeOn Edge IOLs
Number of subjects: 116

Group type: COMPARATOR
Intervention: SI40NB IOLs
Number of subjects: 116
Study: 12816786

Group type: EXPERIMENTAL
Intervention: Atole (high-protein, moderate-energy drink)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Fresco (nonprotein, low-energy drink)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Maternal nutritional supplementation
Number of subjects: 263
Study: 10484799

Group type: EXPERIMENTAL
Intervention: Family-focused asthma intervention
Number of subjects: 1033

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1033
Study: 8839554

Group type: EXPERIMENTAL
Intervention: Omeprazole, 20 mg once a day
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo, 1 tablet twice a day
Number of subjects: 182

Group type: COMPARATOR
Intervention: Misoprostol, 400 micrograms twice a day
Number of subjects: 182
Study: 1503250

Group type: EXPERIMENTAL
Intervention: Intra-uterine insemination with washed sperm
Number of subjects: 41

Group type: COMPARATOR
Intervention: Intra-uterine insemination with split ejaculate
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Intra-uterine insemination with washed sperm (cervical infertility)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Intra-uterine insemination with split ejaculate (cervical infertility)
Number of subjects: 41
Study: 6389394

Group type: EXPERIMENTAL
Intervention: Antimicrobial agents (antibiotics)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 0
Study: 31464020

Group type: EXPERIMENTAL
Intervention: Manual sphygmomanometer (MS) in sinus rhythm (SR)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Automated sphygmomanometer (AS) in sinus rhythm (SR)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PulseCor R6.5 (PC) in sinus rhythm (SR)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Manual sphygmomanometer (MS) in atrial fibrillation (AF)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Automated sphygmomanometer (AS) in atrial fibrillation (AF)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PulseCor R6.5 (PC) in atrial fibrillation (AF)
Number of subjects: 100
Study: 30113959

Group type: EXPERIMENTAL
Intervention: 6-week Iyengar yoga intervention
Number of subjects: 18
Study: 26742176

Group type: EXPERIMENTAL
Intervention: Fuji II LC resin‐modified glass ionomer (RMGI)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Zonalin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IRM
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Coltosol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Not restored (negative control)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intact teeth (positive control)
Number of subjects: 90
Study: 24215940

Group type: EXPERIMENTAL
Intervention: Robotic prostatectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open prostatectomy
Number of subjects: 0
Study: 22504223

Group type: EXPERIMENTAL
Intervention: Exercise group (400 kcal/session, 5 days/week, for 10 months)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Exercise group (600 kcal/session, 5 days/week, for 10 months)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Non-exercise control group
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Both exercise groups
Number of subjects: 141
Study: 19561460

Group type: EXPERIMENTAL
Intervention: Early endoscopic retrograde cholangiopancreatography (ERCP)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 153
Study: 17587396

Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg/day)
Number of subjects: 97
Study: 15579728

Group type: EXPERIMENTAL
Intervention: Standardized polyphenol extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects (normal subjects)
Number of subjects: 0
Study: 12021585

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 46
Study: 9808599

Group type: EXPERIMENTAL
Intervention: Intensive medical therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Coronary angioplasty (PTCA)
Number of subjects: 44
Study: 7608823

Group type: EXPERIMENTAL
Intervention: 2'-3' dideoxyinosine (ddI)
Number of subjects: 34
Study: 1971320

Group type: EXPERIMENTAL
Intervention: 600 mg mifepristone, given orally 48 h before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 7017139

Group type: EXPERIMENTAL
Intervention: Anal dilator used after anal stretch
Number of subjects: 89

Group type: COMPARATOR
Intervention: Anal stretch alone (Control)
Number of subjects: 89
Study: 30451757

Group type: EXPERIMENTAL
Intervention: Oxymetazoline 1.0%
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 28118423

Group type: EXPERIMENTAL
Intervention: Capsaicin (30 μL of 5% capsaicin)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 12
Study: 26123356

Group type: EXPERIMENTAL
Intervention: HUC‐MSCs
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: BM‐MNCs
Number of subjects: 79

Group type: COMPARATOR
Intervention: CABG alone (Control)
Number of subjects: 79
Study: 25150401

Group type: EXPERIMENTAL
Intervention: AA attendance during treatment (12 weeks of outpatient treatment)
Number of subjects: 1726
Study: 21676165

Group type: EXPERIMENTAL
Intervention: Gabapentin (600 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Active placebo (12.5 mg diphenhydramine)
Number of subjects: 120
Study: 19112061

Group type: EXPERIMENTAL
Intervention: Plain articaine 50 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Plain prilocaine 50 mg
Number of subjects: 72
Study: 17977159

Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 31

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 31
Study: 16680610

Group type: EXPERIMENTAL
Intervention: ROB‐ML (robotics and motor learning)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: FNS‐ML (functional neuromuscular stimulation and motor learning)
Number of subjects: 12
Study: 12181997

Group type: EXPERIMENTAL
Intervention: Magnetic field stimulation using VIOFOR JPS
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no magnetic stimulation)
Number of subjects: 76
Study: 9814448

Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy (methylprednisolone, 1 g i.v. for 2 consecutive days a week for 6 weeks)
Number of subjects: 10
Study: 7657044

Group type: EXPERIMENTAL
Intervention: alpha‐interferon (IFN) alfa‐2b (6 MU 3 times weekly for the first month and 3 MU for the next 11 months)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: alpha‐interferon (IFN)
Number of subjects: 63

Group type: COMPARATOR
Intervention: no treatment (control group)
Number of subjects: 63
Study: 2511695

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide-2-mononitrate (IS-2-MN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (IS-5-MN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 0
Study: 8070

Group type: EXPERIMENTAL
Intervention: Salmefamol 200 mug
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salbutamol 200 mug
Number of subjects: 0
Study: 31056441

Group type: EXPERIMENTAL
Intervention: GLPG2222 200 mg (FLAMINGO)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: GLPG2222 300 mg (ALBATROSS)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (FLAMINGO)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (ALBATROSS)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: GLPG2222
Number of subjects: 96
Study: 27942999

Group type: EXPERIMENTAL
Intervention: Algorithm-based treatments (AT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 100
Study: 25743731

Group type: EXPERIMENTAL
Intervention: CVD prevention education program (8 sessions over 8 weeks)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 23912069

Group type: EXPERIMENTAL
Intervention: Ad with warning about adverse side effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ad noting benefits with warning of risky side effects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ad noting only benefits
Number of subjects: 0
Study: 20869890

Group type: EXPERIMENTAL
Intervention: Endovascular aortic aneurysm repair (EVAR)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 360
Study: 19154473

Group type: EXPERIMENTAL
Intervention: Surveillance scheme for NMI UC patients
Number of subjects: 150

Group type: COMPARATOR
Intervention: Age- and gender-matched healthy population
Number of subjects: 150
Study: 19124904

Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 16

Group type: COMPARATOR
Intervention: No stretching (control)
Number of subjects: 16
Study: 15514382

Group type: EXPERIMENTAL
Intervention: Cancer consultation preparation package (CCPP)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control booklet
Number of subjects: 164
Study: 11783834

Group type: COMPARATOR
Intervention: Manipulation and mobilization for chronic low back pain
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manipulation and mobilization for chronic post-traumatic headache
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manipulation and mobilization for chronic neck pain
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manipulation and mobilization for chronic soft tissue shoulder disorders
Number of subjects: 0
Study: 9393429

Group type: EXPERIMENTAL
Intervention: Increased awareness of tobacco use as a risk factor for osseointegration of dental implants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discretionary inclusion-exclusion criteria changes
Number of subjects: 0
Study: 8481628

Group type: EXPERIMENTAL
Intervention: Allopurinol (test preparation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxipurinol (active metabolite)
Number of subjects: 0
Study: 3546751

Group type: EXPERIMENTAL
Intervention: Automatic external defibrillators (AEDs)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Standard defibrillators
Number of subjects: 321
Study: 30928927

Group type: EXPERIMENTAL
Intervention: M2M (movement-to-music)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: M2M plus social networking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control (AC)
Number of subjects: 0
Study: 30575071

Group type: EXPERIMENTAL
Intervention: A4FTp (T8 criterion)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: SD-OCT (any RNFL parameter p < 1% level)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: FDT (one or more locations missed at p < 5% level)
Number of subjects: 78
Study: 26701362

Group type: EXPERIMENTAL
Intervention: Active NMES
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo NMES
Number of subjects: 73
Study: 24814528

Group type: EXPERIMENTAL
Intervention: pioglitazone 30 mg/day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (15 women)
Number of subjects: 15
Study: 22747647

Group type: EXPERIMENTAL
Intervention: Diflunisal administration
Number of subjects: 13
Study: 20727660

Group type: EXPERIMENTAL
Intervention: Corticosteroids (systemic)
Number of subjects: 12089

Group type: EXPERIMENTAL
Intervention: Bronchial dilators
Number of subjects: 12089

Group type: EXPERIMENTAL
Intervention: Anti-psychotic medication
Number of subjects: 12089

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 12089

Group type: EXPERIMENTAL
Intervention: Myocardial infarction
Number of subjects: 12089

Group type: EXPERIMENTAL
Intervention: Heart failure
Number of subjects: 12089

Group type: EXPERIMENTAL
Intervention: Ischemic heart disease
Number of subjects: 12089

Group type: EXPERIMENTAL
Intervention: Cardiac dysrhythmia
Number of subjects: 12089
Study: 18850554

Group type: EXPERIMENTAL
Intervention: Nonpenetrating deep sclerectomy (NPDS) with reticulated hyaluronic acid (SK-GEL) scleral implant
Number of subjects: 93

Group type: COMPARATOR
Intervention: Punch trabeculectomy (PT)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both NPDS and PT (with Mitomycin C 0.2 mg/mL applied intraoperatively)
Number of subjects: 93
Study: 15911747

Group type: EXPERIMENTAL
Intervention: SphygmoCor central pulse pressure
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Brachial artery pressure
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Brachial-to-radial artery pulse pressure amplification
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Brachial artery pulse pressure
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Calibration of radial pressure wave with radial instead of brachial artery pressures
Number of subjects: 44
Study: 12370858

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 22
Study: 9923768

Group type: EXPERIMENTAL
Intervention: Patients with AVM
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison group (cerebral aneurysm or low-grade tumor)
Number of subjects: 44
Study: 7594076

Group type: EXPERIMENTAL
Intervention: Directional coronary atherectomy
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Percutaneous coronary angioplasty
Number of subjects: 1012
Study: 1980278

Group type: EXPERIMENTAL
Intervention: Bisoprolol (20 mg QD)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 7461879

Group type: EXPERIMENTAL
Intervention: Short-term alcohol treatment intervention
Number of subjects: 436

Group type: COMPARATOR
Intervention: Minimal exposure (comparison group)
Number of subjects: 436
Study: 31958549

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 0

Group type: COMPARATOR
Intervention: Men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall response
Number of subjects: 0
Study: 30588542

Group type: EXPERIMENTAL
Intervention: INTACT method for RNA-sequencing in endosperm
Number of subjects: 0
Study: 28953798

Group type: EXPERIMENTAL
Intervention: Listening to Mozart's sonata for two pianos in D major, K448, once a day for six months
Number of subjects: 12

Group type: COMPARATOR
Intervention: Baseline period
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control period
Number of subjects: 12
Study: 25663221

Group type: EXPERIMENTAL
Intervention: 5-V anterior nucleus of the thalamus (ANT) stimulation
Number of subjects: 0
Study: 23565581

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination duloxetine-methadone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 21422119

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity during school playtime
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical antisocial behavior
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal antisocial behavior
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time spent alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Engagement in playground games
Number of subjects: 0
Study: 19586568

Group type: EXPERIMENTAL
Intervention: 6 mg lutein/d (Group L6)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 12 mg lutein/d (Group L12)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (Group Placebo)
Number of subjects: 37
Study: 17704981

Group type: EXPERIMENTAL
Intervention: Cranberry juice
Number of subjects: 0
Study: 14998444

Group type: EXPERIMENTAL
Intervention: Closed System (CS) aspiration
Number of subjects: 26

Group type: COMPARATOR
Intervention: Open System (OS) aspiration
Number of subjects: 26
Study: 11709012

Group type: EXPERIMENTAL
Intervention: Cycloplegic retinoscopy
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Cylindrical error of 1 diopter or more
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Myopia and anisometropia
Number of subjects: 514